Bio-Gene Technology Plans Major Share and Option Issue on ASX

BioPharma DiveLegend surges on early data for ‘in vivo’ lymphoma cell therapy

WatersTranscript : Waters Corporation Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 10 - marketscreener.com

Endpoints NewsWhat it will take for more employer GLP-1 coverage

BioPharma DiveHouse bill aims to crack down on China biotech deals

BioPharma DiveNewLimit’s $435M megaround; Lilly’s busy dealmaking week

Lonza NewsLonza Enhances Biologics Preclinical Development Offering - Contract Pharma

LabiotechHighlights of ASCO 2026: how is cancer care evolving?

Clinical OMICsExperienced Physicians Still Beat AI at Skin Cancer Diagnosis

Endpoints NewsRegeneron doubles down on CytomX after other pharmas walked away

Clinical OMICsArthur Caplan: The Right to Life, Liberty, and Pursuit of Health

Endpoints NewsMineralys makes money moves before looming hypertension approval

FierceBiotechRegeneron pays $37M, adds $2B in biobucks to expand CytomX pact